David Smith Email

EVP, Head Chemical Operations . Aligos Therapeutics

South San Francisco, CA

Location

d*****@aligos.com

Primary Email

Current Roles

Employees:
99
Revenue:
$4M
About
Company Mission: To become a world leader in the development of targeted, curative therapies for hepatologic diseases and viral infections, including chronic hepatitis B (CHB), nonalcoholic steatohepatitis (NASH) and hepatocellular carcinoma (HCC). Scientific Overview: Aligos Therapeutics is discovering and developing new classes of compounds that interact directly with disease causing molecules. These approaches are targeting viral nucleic acids and their encoded proteins, as well as oncogenes and their resultant proteins. The company is also pursuing novel therapeutic agents aimed at activation of the immune system to resolve diseases that cause significant morbidity and mortality.
Aligos Therapeutics Address
1 Corporate Dr
South San Francisco, CA
United States

Past Companies

Aligos TherapeuticsExecutive Vice President
Aligos TherapeuticsVice President, Head of Chemical Operations
The Janssen Pharmaceutical Companies of Johnson & JohnsonVice President, Global Research and Development Leader, Hepatology

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.